Supernus Pharmaceuticals, Inc.

Rachunek Zysków i Strat


Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna



index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Rok finansowy 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 4 9 38 0 1 1 12 122 144 215 302 409 393 520 580 667 608 662
Przychód Δ r/r 0.0% 110.0% 326.7% -99.7% 657.5% 84.3% 712.1% 915.4% 18.3% 48.9% 40.6% 35.3% -3.9% 32.5% 11.4% 15.1% -8.9% 8.9%
Marża brutto 100.0% 100.0% 122.6% 12745.3% 100.0% 100.0% 90.8% 95.3% 94.2% 94.4% 95.0% 96.2% 95.8% 89.9% 87.1% 86.9% 72.2% 88.2%
EBIT (mln) -19 -26 4 -40 -38 -42 -62 24 18 54 100 144 149 174 86 67 13 82
EBIT Δ r/r 0.0% 35.8% -115.5% -1099.1% -5.9% 11.7% 46.8% -139.1% -27.1% 206.9% 83.6% 45.1% 2.9% 16.9% -50.5% -21.8% -80.1% 509.3%
EBIT (%) -449.9% -290.9% 10.6% -37851.9% -4701.4% -2849.3% -515.2% 19.9% 12.2% 25.2% 32.9% 35.3% 37.8% 33.4% 14.8% 10.1% 2.2% 12.3%
Koszty finansowe (mln) 2 9 0 0 2 4 8 5 1 5 2 18 23 24 23 7 2 0
EBITDA (mln) -16 -24 5 -38 -37 -43 -62 25 18 56 102 158 170 210 120 150 98 178
EBITDA(%) -386.0% -266.5% 13.7% -36118.9% -4573.5% -2885.7% -511.9% 20.2% 12.7% 25.9% 33.9% 38.7% 43.3% 40.4% 20.7% 22.5% 16.2% 26.9%
Podatek (mln) 2 1 4 -0 -16 1 7 4 1 -41 43 29 34 42 20 0 1 24
Zysk Netto (mln) -17 -33 0 -38 56 -46 -92 20 14 91 57 111 113 127 53 61 1 74
Zysk netto Δ r/r 0.0% 93.8% -101.4% -8461.5% -245.6% -182.6% 99.4% -121.5% -29.5% 550.8% -37.2% 93.8% 1.9% 12.3% -57.9% 13.6% -97.8% 5512.8%
Zysk netto (%) -408.0% -376.7% 1.2% -36285.8% 6974.2% -3127.3% -767.7% 16.3% 9.7% 42.4% 19.0% 27.1% 28.8% 24.4% 9.2% 9.1% 0.2% 11.2%
EPS -1.25 -2.42 -0.21 -2.78 3.64 -2.65 -2.9 0.47 0.29 1.84 1.13 2.13 2.16 2.41 1.01 1.13 0.0241 1.34
EPS (rozwodnione) -1.25 -2.42 -0.21 -2.78 3.64 -2.65 -2.9 0.32 0.28 1.76 1.08 2.05 2.1 2.36 0.98 1.04 0.0237 1.32
Ilośc akcji (mln) 14 14 14 14 14 17 32 42 47 49 51 52 52 53 53 54 55 55
Ważona ilośc akcji (mln) 14 14 14 14 14 17 32 51 51 52 53 54 54 54 54 62 56 56
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD